Milla CE - Search Results

1

Clinical significance of the recovery of Aspergillus species from the respiratory secretions of cystic fibrosis patients.

Milla CE, Wielinski CL, Regelmann WE. Milla CE, et al. Pediatr Pulmonol. 1996 Jan;21(1):6-10. doi: 10.1002/(SICI)1099-0496(199601)21:1<6::AID-PPUL1>3.0.CO;2-R. Pediatr Pulmonol. 1996. PMID: 8776259

2

Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.

Garner HP, Phillips JR, Herron JG, Severson SJ, Milla CE, Regelmann WE. Garner HP, et al. Among authors: milla ce. J Lab Clin Med. 2004 Sep;144(3):127-33. doi: 10.1016/j.lab.2004.04.010. J Lab Clin Med. 2004. PMID: 15454881

3

Longitudinal assessment of lung function from infancy to childhood in patients with cystic fibrosis.

Harrison AN, Regelmann WE, Zirbes JM, Milla CE. Harrison AN, et al. Among authors: milla ce. Pediatr Pulmonol. 2009 Apr;44(4):330-9. doi: 10.1002/ppul.20994. Pediatr Pulmonol. 2009. PMID: 19274621

4

PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection.

Shreve MR, Johnson SJ, Milla CE, Wielinski CL, Regelmann WE. Shreve MR, et al. Among authors: milla ce. Am J Respir Crit Care Med. 1997 Mar;155(3):984-9. doi: 10.1164/ajrccm.155.3.9117036. Am J Respir Crit Care Med. 1997. PMID: 9117036

5

Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.

Kharbanda S, Panoskaltsis-Mortari A, Haddad IY, Blazar BR, Orchard PJ, Cornfield DN, Grewal SS, Peters C, Regelmann WE, Milla CE, Baker KS. Kharbanda S, et al. Among authors: milla ce. Biol Blood Marrow Transplant. 2006 Apr;12(4):430-7. doi: 10.1016/j.bbmt.2005.12.026. Biol Blood Marrow Transplant. 2006. PMID: 16545727 Free article. Clinical Trial.

6

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.

Zirbes JM, Milla CE. Zirbes JM, et al. Among authors: milla ce. Pediatr Pulmonol. 2008 Jun;43(6):607-10. doi: 10.1002/ppul.20804. Pediatr Pulmonol. 2008. PMID: 18433040

7

High-strength pancreatic enzymes.

Milla CE, Wielinski CL, Warwick WJ. Milla CE, et al. Lancet. 1994 Mar 5;343(8897):599. Lancet. 1994. PMID: 7906348 No abstract available.

8

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.

Gibson RL, Retsch-Bogart GZ, Oermann C, Milla C, Pilewski J, Daines C, Ahrens R, Leon K, Cohen M, McNamara S, Callahan TL, Markus R, Burns JL. Gibson RL, et al. Pediatr Pulmonol. 2006 Jul;41(7):656-65. doi: 10.1002/ppul.20429. Pediatr Pulmonol. 2006. PMID: 16703579 Clinical Trial.

9

Risk of death in cystic fibrosis patients with severely compromised lung function.

Milla CE, Warwick WJ. Milla CE, et al. Chest. 1998 May;113(5):1230-4. doi: 10.1378/chest.113.5.1230. Chest. 1998. PMID: 9596299

10

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.

Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin PL, Milla C, Marshall B, Lavange L, Engels J, Mathews D, Gorden J, Schaberg A, Williams J, Ramsey B; Cystic Fibrosis Foundation Therapeutics Development Network. Deterding R, et al. Pediatr Pulmonol. 2005 Apr;39(4):339-48. doi: 10.1002/ppul.20192. Pediatr Pulmonol. 2005. PMID: 15704203 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters